Protect Yourself From the Sun if You Have Bullous Pemphigoid (BP)
The immune system of the skin is sensitive to the environment. Sunlight and air temperature normally affect the skin, but, if you have Bullous Pemphigoid (BP), which is an autoimmune disease, getting sun or too much heat can lead to blistering.
Researchers studied 27 people with BP for a year. Examinations were conducted every 3 months and blistering was observed in the participants on the scalp, face, neck, hands, trunk, lower extremities, and mouth. The researchers, then, examined the BP occurrences in the subjects, based on whether the intensity of sun exposure was negligible, regular, or intense.
Additionally, the researchers looked at the medical charts of 232 people with BP for seven years. In particular, the blood tests were examined to see whether the antibody levels varied by the season and sun exposure.
In both groups, increased sun exposure was associated with an increase in blistering – both the severity and presence of blisters. Among the twenty-seven who were observed for a year, their BP was more severe in Spring than in Summer or Winter, and in the areas that had the most sun exposure. What’s more, the first attack usually occurred in the summer, when the sun exposure was greatest and most intense. When antibody tests were also studied, it was evident that the presence of sun exposure, higher temperature, and antibodies were the factors that were most associated with greater severity and frequency of blistering.
An increase of sun exposure, as well as toxins and pollutants in the air from wildfires, can interact with the skin and cause more flares of inflammatory skin conditions, such as BP.
These findings are particularly important in light of climate change. Extreme weather events, such as heat waves, are occurring with greater frequency and severity in some regions. Increased heat and dry conditions have proliferated wildfires, which then add to the pollution and further depletion of the protection of the ozone layer. An increase in sun exposure, as well as toxins and pollutants in the air from wildfires, can interact with the skin and cause more flares of inflammatory skin conditions, such as BP. High temperatures and pollution have been shown to increase hospitalizations for pemphigus. Besides worsening existing conditions, pollutants and heat waves can also increase the amount of people who get the condition.
Existing skin disorders will be exacerbated by weather and vegetation changes. Extreme weather events—as well as the various skin diseases they facilitate—will continue to rise in frequency. Preparing for extreme weather and trying to stay out of the sun are two strategies that seem most necessary to prevent further flares of BP.
Sources:
1. Kyriakis K, et al. International Journal of Dermatology, Vol. 35, No. 7, July 1996
2. Fathi R, Rosenbach M. Current Dermatology Reports (2020) 9:201–209
Latest From Know Rare
From prenatal uncertainty and postpartum anxiety to therapy, grief, and hope, a mother shares her experience raising a child with a rare disease, navigating the healthcare system, finding community, and learning to embrace a different—but deeply meaningful—path as a parent.
A Danon disease study, led by researcher Dr. Barry Greenberg and published in the New England Journal of Medicine, wins an award! The study focuses on gene therapy as a potential treatment option for Danon disease. The study showed early signs that gene therapy may help the hearts of people with Danon disease.
A poster, presented at the European Hematology Association meeting in June, described a study that looked at tiredness (fatigue) in adults with immune thrombocytopenia (ITP). Researchers wanted to see if fatigue was related to bleeding or other health test results.
Lucky Shanmugan was recently featured in Porter Ranch Living, his local magazine, for Father’s Day: in his interview, Lucky talks about Osteogenesis Imperfecta, a rare genetic or heritable disorder of the connective tissue, and the incredible journey towards his official diagnosis.
Here are 9 things Chris Anselmo wishes someone had told him after his rare disease diagnosis.
A family’s hardships and resilience in finding answers and getting a diagnosis for their child, after numerous tests, brain biopsies, and hospitalizations. And the relief but also grief in finally putting a name to the rare disease that affects their child: BCL11B-related disorder.
The Danon Foundation boldly empowers people living with Danon disease, providing trusted information, resources and support to help navigate life, from diagnosis to treatment.
For many families, caregiving for a child with a rare or medically complex condition is a full-time job. The problem is, it’s a job with no training, no time off, and no clear job description. If you’re looking for the light at the end of the tunnel, you don’t have to search alone. Check out some of Paige’s favorite resources.
For most of celiacs, despite months on a strict GF diet, energy stays low and blood work reveals nutrient deficiencies. The lesson? A "gluten-free" label isn't a health guarantee—just a guarantee you'll pay more.
If you’ve been told you have seronegative NMOSD, there’s nearly 50/50 chance you have a different antibody causing your symptoms –MOG antibody.
Therapy Near Me is a nationwide mental health service based in Australia, providing easy access to psychologists, counsellors, behaviour support practitioners and social workers.
At the annual Kidney Week of the American Society of Nephrologists (ASN), the world’s largest kidney healthcare professional organization, new advances in research were highlighted. Over $35 million has been invested in research with the ASN, and there are many treatments in development for IgA Nephropathy (IgAN), with researchers actively investigating more than 20 different drugs.
When I was diagnosed with celiac disease, I thought avoiding bread and pasta would be enough. I quickly learned that living truly gluten-free is far more complex, and I'm sharing my experience to help newly diagnosed individuals understand what lies ahead.
Retinopathy is an eye problem that many people with Danon disease have. It can cause dark spots in the outer part of the eye, blurry or worse vision, and unusual test results on an eye exam. Sometimes these eye changes show up before heart problems, so an eye check can help find the disease early.
A heartfelt story about a mother who found purpose and strength among the tragedy of losing a child diagnosed with an ultra rare genetic disorder.
Kaya Girl Legacy, Inc. is a Florida-based nonprofit founded in memory of Kaya Humbert, a beautiful baby girl born with Sphingosine Phosphate Lyase Insufficiency Syndrome (SPLIS), one of 46 known cases worldwide. The foundation is dedicated to empowering families with knowledge about their genetic health and advocating for early access to genetic testing and rare disease awareness.
A prose poem by Jim Kuhn, a rare warrior living with Sarcoidosis, a rare inflammatory disease.
Rare Mom Laura shares how her family’s prep for Halloween turned into a burst of familial love and creativity, as they all worked together in designing and building a costume for Alden, her medically complex son.
Instead of starting with a newly discovered drug compound, PCOR is a type of research that starts by turning to patients and caregivers and asking, What matters most to you? What questions do we want answered? What symptoms do we wish were better managed? What keeps us up at night?
Four years ago, Michael Grivas’ life suddenly changed when he learned that he had Brugada Syndrome, a genetic disorder in which the electrical activity of the heart is abnormal due to channelopathy. Learn more about his story.
Fatigue is a very common and often debilitating symptom of IgAN. It is linked to disease progression and reduced kidney function, but other factors like inflammation, anemia, and mental health also play a role. In a 2025 study, the majority of patients with IgAN reported fatigue, and patients with more severe proteinuria and lower kidney filtration rates (eGFR) experienced worse fatigue.
Why is it so hard to accept help? Humans often associate help with weakness and loss of independence and control. However, if we reframe our thoughts, accepting help can be viewed as a form of empowerment: showing vulnerability and trusting someone to help us requires great strength.
There is so much mental load with having a rare disease. Rare Human Lindsay shares there are things she does not care about anymore, as she manages rare disease symptoms, specialists, and clinical trials.
Rare Human Lindsay shares her "silver linings." It's not 'what doesn't kill you makes you stronger,' instead it's what doesn't kill you makes you braver. She shares that she has found deeper connections with others, improved her ability to ask for and accept help, and not been as afraid of the word "no."
Journalist and rare disease advocate Lindsay Guentzel breaks down why clinical trials are a lifeline for the rare disease community. With only 5% of known rare diseases having an FDA-approved therapy, trials often represent the only path toward treatment, progress, and hope.
Lindsay was diagnosed with dermatomyositis a couple of years ago. Since then, she has undergone more than 350 doctor appointments, 250+ hours of infusions, 10+ ER visits, while juggling insurance approvals, rides, and her pain and fatigue.
Rare Human Lindsay is in the midst of her first clinical trial for dermatomyositis, a rare inflammatory disease that primarily affects the skin and muscles. So far, she has learned so much about the process and is eager to share some of her insights with the rare disease community.
Nina Wachsman
Nina is the co-founder and president of Know Rare
Nina’s experience goes across therapeutic categories from rare disease like pulmonary arterial hypertension (PAH), autoimmune disease and cancer, and her expertise ranges from market research and strategy to patient and digital marketing.
Additionally, she has been a founder and angel investor of a biotech start-up, helped brand an oncology patient organization, Aim at Melanoma, and worked on patient education for Genentech’s leading HER2 therapy, Herceptin.
Nina is also a mother, grandmother, artist, and author of The Gallery of Beauties, a novel set in the Venice in the early 17th century.